Landscape of genetic infantile epileptic spasms syndrome-A multicenter cohort of 124 children from India.
developmental and epileptic encephalopathy
genetic West
genetic epileptic spasms
genetic infantile spasms
Journal
Epilepsia open
ISSN: 2470-9239
Titre abrégé: Epilepsia Open
Pays: United States
ID NLM: 101692036
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
21
03
2023
accepted:
10
08
2023
medline:
4
12
2023
pubmed:
16
8
2023
entrez:
16
8
2023
Statut:
ppublish
Résumé
Literature on the genotypic spectrum of Infantile Epileptic Spasms Syndrome (IESS) in children is scarce in developing countries. This multicentre collaboration evaluated the genotypic and phenotypic landscape of genetic IESS in Indian children. Between January 2021 and June 2022, this cross-sectional study was conducted at six centers in India. Children with genetically confirmed IESS, without definite structural-genetic and structural-metabolic etiology, were recruited and underwent detailed in-person assessment for phenotypic characterization. The multicentric data on the genotypic and phenotypic characteristics of genetic IESS were collated and analyzed. Of 124 probands (60% boys, history of consanguinity in 15%) with genetic IESS, 105 had single gene disorders (104 nuclear and one mitochondrial), including one with concurrent triple repeat disorder (fragile X syndrome), and 19 had chromosomal disorders. Of 105 single gene disorders, 51 individual genes (92 variants including 25 novel) were identified. Nearly 85% of children with monogenic nuclear disorders had autosomal inheritance (dominant-55.2%, recessive-14.2%), while the rest had X-linked inheritance. Underlying chromosomal disorders included trisomy 21 (n = 14), Xq28 duplication (n = 2), and others (n = 3). Trisomy 21 (n = 14), ALDH7A1 (n = 10), SCN2A (n = 7), CDKL5 (n = 6), ALG13 (n = 5), KCNQ2 (n = 4), STXBP1 (n = 4), SCN1A (n = 4), NTRK2 (n = 4), and WWOX (n = 4) were the dominant single gene causes of genetic IESS. The median age at the onset of epileptic spasms (ES) and establishment of genetic diagnosis was 5 and 12 months, respectively. Pre-existing developmental delay (94.3%), early age at onset of ES (<6 months; 86.2%), central hypotonia (81.4%), facial dysmorphism (70.1%), microcephaly (77.4%), movement disorders (45.9%) and autistic features (42.7%) were remarkable clinical findings. Seizures other than epileptic spasms were observed in 83 children (66.9%). Pre-existing epilepsy syndrome was identified in 21 (16.9%). Nearly 60% had an initial response to hormonal therapy. Our study highlights a heterogenous genetic landscape and phenotypic pleiotropy in children with genetic IESS.
Identifiants
pubmed: 37583270
doi: 10.1002/epi4.12811
pmc: PMC10690684
doi:
Substances chimiques
ALG13 protein, human
EC 2.4.1.-
N-Acetylglucosaminyltransferases
EC 2.4.1.-
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1383-1404Informations de copyright
© 2023 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Références
Lancet Neurol. 2016 Mar;15(3):304-16
pubmed: 26597089
Epilepsia Open. 2023 Dec;8(4):1383-1404
pubmed: 37583270
Epilepsia Open. 2021 Dec;6(4):736-747
pubmed: 34653320
Seizure. 2020 Feb;75:49-54
pubmed: 31874359
Epilepsia. 2017 Apr;58(4):522-530
pubmed: 28276060
Epilepsia. 2012 Aug;53(8):1387-98
pubmed: 22612257
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Epilepsy Behav Rep. 2020 Oct 17;14:100397
pubmed: 33196034
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612
pubmed: 33237311
J Pediatr Neurosci. 2021 Jul-Sep;16(3):212-217
pubmed: 36160609
Pediatr Neurol. 2012 May;46(5):276-80
pubmed: 22520347
Epilepsy Res. 2020 Oct;166:106398
pubmed: 32593896
Hum Mol Genet. 2014 Sep 15;23(18):4846-58
pubmed: 24781210
Seizure. 2022 Aug;100:15-20
pubmed: 35716448
Nature. 2013 Sep 12;501(7466):217-21
pubmed: 23934111
Epilepsia Open. 2020 Aug 11;5(3):461-474
pubmed: 32913954
Neurol Int. 2021 Nov 03;13(4):555-568
pubmed: 34842787
Pediatr Neurol. 2018 Oct;87:48-56
pubmed: 30174244
Eur J Paediatr Neurol. 2020 Jan;24:15-23
pubmed: 31882278
Epilepsia. 2010 Oct;51(10):2168-74
pubmed: 20726878
Nat Genet. 2018 Jul;50(7):1048-1053
pubmed: 29942082
Seizure. 2021 Nov;92:52-55
pubmed: 34425480
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Indian J Pediatr. 2019 Nov;86(11):1072-1073
pubmed: 31444733
Epilepsia Open. 2016 Jul 28;1(1-2):61-66
pubmed: 29588929
Epilepsia. 2004 Nov;45(11):1416-28
pubmed: 15509243
Pediatr Neurol. 2020 Jul;108:54-64
pubmed: 32305143
Epilepsia. 2022 Jun;63(6):1349-1397
pubmed: 35503712
Indian J Pediatr. 2022 Aug;89(8):765-770
pubmed: 34623615
Neurol Genet. 2021 Nov 15;7(6):e613
pubmed: 34790866
Eur J Paediatr Neurol. 2020 Mar;25:134-138
pubmed: 31791873
Epilepsia. 2015 Apr;56(4):617-25
pubmed: 25779538
Epilepsia. 2020 Apr;61(4):702-713
pubmed: 32133641
Epilepsy Res. 2015 Jan;109:155-62
pubmed: 25524855
JAMA Pediatr. 2023 Mar 1;177(3):258-266
pubmed: 36716045
Epilepsy Res. 2021 Jul;173:106629
pubmed: 33862315